Oliver Sartor

Oliver Sartor is an American oncologist and research scientist. He is currently the chair of the genitourinary cancer disease group and director of radiopharmaceutical clinical trials at Mayo Clinic Rochester. He was previously the assistant dean for oncology and the C.E. and Bernadine Laborde Professor of Cancer Research, Medicine and Urology Departments at the Tulane School of Medicine in New Orleans, Louisiana. His research has mainly focused on translational science and clinical research trials of advanced prostate cancer since 1990 and he is recognized as an expert in that field through his contributions to the practice and the publishing of over 500 peer-reviewed articles and numerous book chapters and reviews. Sartor also serves as the editor-in-chief of the bimonthly journal ''Clinical Genitourinary Cancer'' that mainly focuses on research in genitourinary oncology. Provided by Wikipedia
Showing 1 - 20 results of 26 for search 'Oliver Sartor', query time: 0.08s Refine Results
  1. 1
    Prostate specific membrane antigen binding radiopharmaceuticals: Current data and new concepts

    Prostate specific membrane antigen binding radiopharmaceuticals: Current data and new concepts by Oliver Sartor, Oliver Sartor, Ali Baghian, Ali Baghian

    Published 2022-12-01
    Get full text
    Article
  2. 2
    Acute pancreatitis and biliary obstruction from metastatic lymph node compression during [177Lu] Lu-PSMA-617 therapy: a case report

    Acute pancreatitis and biliary obstruction from metastatic lymph node compression during [177Lu] Lu-PSMA-617 therapy: a case report by Gokce Belge Bilgin, Patrick J. Navin, Derek R. Johnson, Oliver Sartor, Oliver Sartor, Oliver Sartor, Ayse Tuba Kendi

    Published 2024-10-01
    Get full text
    Article
  3. 3
    Androgen receptor variant-7: an important predictive biomarker in castrate resistant prostate cancer

    Androgen receptor variant-7: an important predictive biomarker in castrate resistant prostate cancer by Oliver Sartor, Yan Dong

    Published 2015-06-01
    Get full text
    Article
  4. 4
    Cooperative Carbon Alliances: Defining an Agenda for Global Industrial Decarbonisation

    Cooperative Carbon Alliances: Defining an Agenda for Global Industrial Decarbonisation by Aylin Shawkat, Oliver Sartor

    Published 2022-06-01
    Get full text
    Article
  5. 5
    Long-term survival of participants in the prostate cancer prevention trial

    Long-term survival of participants in the prostate cancer prevention trial by Jonathan L Silberstein, Oliver Sartor

    Published 2014-06-01
    Get full text
    Article
  6. 6
    Status of PSMA-targeted radioligand therapy in prostate cancer: current data and future trials

    Status of PSMA-targeted radioligand therapy in prostate cancer: current data and future trials by Albert Jang, Ayse T. Kendi, Oliver Sartor

    Published 2023-03-01
    Get full text
    Article
  7. 7
    Accelerating Sustainable Mobility with Autonomous Vehicles

    Accelerating Sustainable Mobility with Autonomous Vehicles by Laura Brimont, Mathieu Saujot, Oliver Sartor

    Published 2017-12-01
    Get full text
    Article
  8. 8
    Management of localized prostate cancer: the pendulum swings (back to the middle)

    Management of localized prostate cancer: the pendulum swings (back to the middle) by Winston Vuong, Oliver Sartor, Sumanta K Pal

    Published 2014-08-01
    Get full text
    Article
  9. 9
    Radium-223 in metastatic castration resistant prostate cancer

    Radium-223 in metastatic castration resistant prostate cancer by Winston Vuong, Oliver Sartor, Sumanta K Pal

    Published 2014-06-01
    Get full text
    Article
  10. 10
    Critical appraisal of cabazitaxel in the management of advanced prostate cancer

    Critical appraisal of cabazitaxel in the management of advanced prostate cancer by Sumanta Kumar Pal, Przemyslaw Twardowski, Oliver Sartor

    Published 2010-12-01
    Get full text
    Article
  11. 11
    Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer

    Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resist... by Johann de Bono, Liji Shen, Oliver Sartor

    Published 2016-03-01
    Get full text
    Article
  12. 12
    Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer 177Lu-PSMA-617 therapy

    Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer 177Lu-PSMA-617 therapy by Gokce Belge Bilgin, Cem Bilgin, Daniel S. Childs, Jacob J. Orme, Brian J. Burkett, Ann T. Packard, Derek R. Johnson, Matthew P. Thorpe, Irbaz Bin Riaz, Thorvardur R. Halfdanarson, Geoffrey B. Johnson, Geoffrey B. Johnson, Oliver Sartor, Oliver Sartor, Oliver Sartor, Ayse Tuba Kendi

    Published 2024-07-01
    Get full text
    Article
  13. 13
    An Integrative Genomics Approach for Associating Genome-Wide Association Studies Information With Localized and Metastatic Prostate Cancer Phenotypes

    An Integrative Genomics Approach for Associating Genome-Wide Association Studies Information With Localized and Metastatic Prostate Cancer Phenotypes by Chindo Hicks, Ritika Ramani, Oliver Sartor, Ritu Bhalla, Lucio Miele, Zodwa Dlamini, Njabulo Gumede

    Published 2017-03-01
    Get full text
    Article
  14. 14
    Early prostate-specific antigen response post-abiraterone as predictor of overall survival in metastatic castrate-resistant prostate cancer

    Early prostate-specific antigen response post-abiraterone as predictor of overall survival in metastatic castrate-resistant prostate cancer by Joshua P. Schiff, Patrick Cotogno, Allison Feibus, Peter Steinwald, Elisa Ledet, Brian Lewis, Oliver Sartor

    Published 2019-05-01
    Get full text
    Article
  15. 15
    Metastatic Cancer of Cowper's Gland: A Rare Cancer Managed Successfully by Molecular Profiling

    Metastatic Cancer of Cowper's Gland: A Rare Cancer Managed Successfully by Molecular Profiling by Charles E. Myers, Zoran Gatalica, Anthony Spinelli, Michael Castro, Erica Linden, Oliver Sartor, Mathew Sargent

    Published 2014-01-01
    Get full text
    Article
  16. 16
    A Novel Controlled PTEN-Knockout Mouse Model for Prostate Cancer Study

    A Novel Controlled PTEN-Knockout Mouse Model for Prostate Cancer Study by Sen Liu, Bing Zhang, Bing Zhang, Brian G. Rowan, S. Michal Jazwinski, S. Michal Jazwinski, Asim B. Abdel-Mageed, Chad Steele, Alun R. Wang, Oliver Sartor, Oliver Sartor, Tianhua Niu, Qiuyang Zhang, Qiuyang Zhang, Qiuyang Zhang

    Published 2021-06-01
    Get full text
    Article
  17. 17
    Editorial: Prostate cancer genomics: Application at different stages of a patient’s journey

    Editorial: Prostate cancer genomics: Application at different stages of a patient’s journey by Darren M. C. Poon, Darren M. C. Poon, Arun Azad, Elena Castro, Ravindran Kanesvaran, Oliver Sartor

    Published 2022-11-01
    Get full text
    Article
  18. 18
    Neutropenia, neutrophilia, and neutrophil–lymphocyte ratio as prognostic markers in patients with metastatic castration-resistant prostate cancer

    Neutropenia, neutrophilia, and neutrophil–lymphocyte ratio as prognostic markers in patients with metastatic castration-resistant prostate cancer by Alexander Meisel, Ronald de Wit, Stephane Oudard, Oliver Sartor, Frank Stenner-Liewen, Zhenming Shun, Meredith Foster, Ayse Ozatilgan, Mario Eisenberger, Johann S. de Bono

    Published 2022-05-01
    Get full text
    Article
  19. 19
    Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA

    Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA by Neeraj Agarwal, Oliver Sartor, Brian Lewis, Hani Babiker, Elisa Ledet, Lesli Kiedrowski, Pedro Barata, Roberto Nussenzveig, Benjamin Gerendash, Ellen Jaeger, Whitley Hatton, Jodi Layton, Alan Bryce, Cy Stein, Philip Saylor

    Published 2020-10-01
    Get full text
    Article
  20. 20
    Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort

    Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort by Pedro Barata, Whitley Hatton, Arpita Desai, Vadim Koshkin, Ellen Jaeger, Charlotte Manogue, Patrick Cotogno, Malcolm Light, Brian Lewis, Jodi Layton, Oliver Sartor, Arnab Basu, Deepak Kilari, Hamid Emamekhoo, Mehmet A. Bilen

    Published 2020-10-01
    Get full text
    Article

Search Tools: